COLOPHON / CONTACT
Contact the Editorial Desk
Corrections welcome. Clinical and commercial questions declined, for the reasons below.
Corrections and citation queries
The most useful message this desk receives is a correction. A figure quoted loosely. A species attached to the wrong number. A trial that has posted updated results. A regulatory status that has moved. A peer-reviewed study on any of the four compounds covered here that belongs on the reference list.
Corrections that name three things are the ones that can be acted on quickly: which page, the exact passage in question, and the supporting source with a DOI or PubMed identifier where one exists. In that form a proposed change can be checked against its source before anything is rewritten.
Pharmacokinetic corrections are especially welcome, because this desk applies a deliberately strict sourcing rule to half-life figures and would rather be told it has left a well-supported number out than quietly carry a badly supported one.
Editorial mailbox: editors@peptide-institute.com
What this desk cannot answer
Three categories of message go unanswered, and it is fairer to say so here than to leave a sender waiting.
Dosing questions. How much, how often, for how long, and how to convert one schedule into another. This desk reports measured durations and cited trial protocols; it does not construct intervals, and it will not do so privately either.
Personal medical questions. Whether a compound suits a particular person, interacts with a particular medication, or explains a particular symptom. Those need a clinician with access to a history, and no correspondence can substitute for one.
Sourcing and purchasing. Where to obtain any compound described here, which supplier to use, what a fair price is. Nothing on this site is for sale and no supplier is recommended.